Monte Rosa Therapeutics

News mentioning Monte Rosa Therapeutics · Wikidata · RSS

Top stories

Latest

1. Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Rating Raised to "Strong-Buy" at HC Wainwrightthemarketsdaily.com · 2026-10-02 11:53 UTC · story
2. Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD RiskGlobeNewswire — public companies · 2026-10-01 11:00 UTC · 1 more reports